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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYEpiblast stem cells (EpiSCs) in mice and rats are primed pluripotent stem cells (PSCs). They barely contribute to chimeric embryos when
injected into blastocysts. Reprogramming of EpiSCs to embryonic stem cell (ESC)-like cells (rESCs) may occur in response to LIF-STAT3
signaling; however, low reprogramming efficiency hampers potential use of rESCs in generating chimeras. Here, we describe dramatic
improvement of conversion efficiency from primed to naive-like PSCs through upregulation of E-cadherin in the presence of the cytokine
LIF. Analysis revealed that blocking nuclear localization of b-CATENINwith small-molecule inhibitors significantly enhances reprogram-
ming efficiency of mouse EpiSCs. Although activation of Wnt/b-catenin signals has been thought desirable for maintenance of naive
PSCs, this study provides the evidence that inhibition of nuclear translocation of b-CATENIN enhances conversion of mouse EpiSCs
to naive-like PSCs (rESCs). This affords better understanding of gene regulatory circuits underlying pluripotency and reprogramming
of PSCs.INTRODUCTION
Pluripotent stem cells (PSCs) can be classed as either naive
or primed (Nichols and Smith, 2009). Mouse embryonic
stem cells (ESCs) are naive PSCs derived from inner cell
mass (ICM) of preimplantation blastocysts (Evans and
Kaufman, 1981; Martin, 1981). Their naive state is main-
tained in an appropriate culture medium containing leuke-
mia inhibitory factor (LIF) together with serum or with
bone morphogenetic protein 4 (BMP4) (Smith et al.,
1988; Ying et al., 2003). Media without LIF and supple-
mented with inhibitors of GSK3b andMAPK suffice to sup-
port long-term maintenance of naive PSCs (Ying et al.,
2008). Epiblast stem cells (EpiSCs) are primed PSCs derived
from postimplantation epiblasts; their self-renewal ability
is maintained by activin A and basic fibroblast growth fac-
tor (bFGF) signaling (Brons et al., 2007; Tesar et al., 2007).
Naive and primed PSCs are distinguished from one another
by differences in signaling pathways that maintain plurip-
otency. In contrast to mouse ESCs, however, mouse EpiSCs
are barely able to contribute to chimeras when injected
into blastocysts, suggesting that a definitive difference be-
tween naive and primed PSCs exists with respect to ability
to contribute to chimeras.
Genetic manipulation by overexpression of exogenous
factors such asNanog, Klf2, and Prdm14 enables conversion
of mouse EpiSCs to ESC-like cells (rESCs) (Gillich et al.,
2012; Silva et al., 2009). Furthermore, transition of mouse
EpiSCs to rESCs rarely occurs even after stimulation withStem CeLIF-STAT3 signaling (Bao et al., 2009). However, the cellular
mechanisms that limit reprogramming efficiency remain
unclear.
Pluripotency in nonrodent PSCs is more like that in ro-
dent primed-PSCs (Nichols and Smith, 2009), so that
chimeric animals derived from PSCs are reported only in
work with rodents (Nichols and Smith, 2009). Nonrodent
PSCs thus are expected not to contribute to chimeras
(one reason why knockout or transgenic studies have not
been done using nonrodent mammals). We investigated
the conditions for efficient conversion of primed PSCs to
naive-like PSCs as part of generation of nonrodent naive
PSCs.
Forced expression of E-cadherin in mouse EpiSCs under
primed-PSC culture conditions promotes ICM develop-
ment after blastocyst injection and results in generation
of chimericmice without reprogramming to the naive state
(Ohtsuka et al., 2012). E-cadherin is a functional factor
that can cooperate with reprogramming factors to promote
generation of induced pluripotent stem cells (iPSCs) from
somatic cells under naive-PSC culture conditions (Chen
et al., 2010). These findings raised the possibility that E-cad-
herin upregulation under appropriate culture conditions
might enhance reprogramming of primed PSCs. We there-
fore investigated the effects of E-cadherin upregulation in
mouse EpiSCs under various culture conditions. We found
that combining E-cadherin upregulationwith LIF treatment
dramatically improves rates of conversion of mouse EpiSCs
to naive-like PSCs.ll Reports j Vol. 4 j 103–113 j January 13, 2015 j ª2015 The Authors 103
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Reprogramming of Epiblast Stem CellsE-CADHERIN specifically binds b-CATENIN and regu-
lates its nuclear translocation (Conacci-Sorrell et al.,
2003; Sasaki et al., 2000; Stockinger et al., 2001). We found
that nuclear translocation of b-CATENIN is negatively
regulated by E-cadherin overexpression in mouse EpiSCs.
Instead of upregulating E-cadherin expression, we used
small-molecule inhibitors of Wnt signaling to study the
role of such signaling in conversion of primed PSCs to
naive-like PSCs. Interestingly, as did overexpression of
E-cadherin, blocking nuclear localization of b-CATENIN
significantly enhanced the efficiency of mouse EpiSCs
conversion to naive-like PSCs in response to LIF. Our in-
vestigations thus provide insight into the significance of
E-cadherin and b-CATENIN as well as into approaches for
increasing efficiency of conversion of primed PSCs to
naive-like PSCs.RESULTS
Overexpression of E-cadherin in the Presence of LIF
Signaling Affects Pluripotency of Mouse EpiSCs
Culture conditions affect aspects of mouse EpiSC pluri-
potency (Bao et al., 2009) and artificial upregulation of
E-cadherin enables chimera formation by mouse EpiSCs
(Ohtsuka et al., 2012). We inferred that E-cadherin upregu-
lation and appropriate culture conditions might in combi-
nation affect the pluripotentiality of primed PSCs (that is,
their capacity to shift between primed-pluripotent and
naive-pluripotent status). To test this hypothesis, we inves-
tigated the effect of upregulation of E-cadherin in mouse
EpiSCs under various culture conditions.Figure 1. E-cadherin-Overexpressing Mouse EpiSCs Show Highly E
(A) Schematic diagram of doxycycline-inducible system for the expre
(B) Western blotting analyses for E-CADHERIN in mouse EB3DR ESCs (E
EB3DR EpiSCs cultured with or without doxycycline (2 mg/ml) for 2 d
(C) FACS analysis of E-CADHERIN expression levels in transgenic mo
doxycycline for 2 days.
(D) Time schedule of all experiments with or without doxycycline in mo
bFGF) and naive (N2B27 + LIF).
(E) FACS analysis of CD31-positive cells in mouse EB3DR EpiSC (DsRe
expressing cells after culturing with or without doxycycline for 7 day
(F) Average of PECAM1-expressing cells associated with (E). The fr
E-cadherin upregulated mouse EpiSCs in the presence of LIF (mean ±
(G) Timing and efficiency of PECAM1 expression. In the presence of
pressing status differ significantly from those seen under other condit
**p < 0.01).
(H) Photomicrograph of PECAM1-expressing cells obtained from E-ca
PECAM1-expressing cells occurred as dome-like compact colonies. Sca
(I) Live-born chimeric mice obtained from DsRed-marked mouse Ecad
(J) Chimeric mice obtained by injection of mouse E-cad-rESCs (ag
contribution from mouse E-cad-rESCs.
See also Figure S1 and Table S2.
Stem CeTo generate E-cadherin-overexpressing mouse EpiSCs, we
constructed a E-cadherin inducible lentiviral vector. This
was derived from a doxycycline (Dox)-dependent in-
ducible vector (Yamaguchi et al., 2012) (Figure 1A). We
introduced this lentiviral vector into a mouse EpiSC line
obtained from DsRed-marked mouse EB3 ESCs (EB3DR
ESCs) (Niwa et al., 2002; Ogawa et al., 2004). We injected
EB3DR mouse ESCs into blastocysts and obtained a
DsRed-expressing mouse EpiSC line (EB3DR EpiSC) from
E6.5 epiblast. Established EB3DR-EpiSCs were confirmed
not to form chimeras when injected into blastocysts (Table
S2 available online). E-cadherin-inducible mouse EB3DR
EpiSCs were purified for green fluorescent protein (GFP)
expression by fluorescence-activated cell sorting (FACS).
We next assessed E-CADHERIN expression in these
mouse EpiSCs by western blotting and FACS analysis (Fig-
ures 1B and 1C). E-CADHERIN expression was upregulated
by Dox compared to a control without Dox and to wild-
type mouse EpiSCs (Figure 1B). FACS analysis also showed
that E-CADHERIN expression levels increased after Dox
treatment (Figure 1C).
To examine the effects of E-cadherin overexpression in the
reprogramming process, we explored the conversion of
mouse EpiSCs to rESCs (Bao et al., 2009) under various cul-
ture conditions such as ESM plus bFGF (typical expansion
medium for primed PSCs) and N2B27 plus LIF including
the MECK inhibitor PD0325901 (PD) combined with the
GSK3b inhibitor CHIR99021 (CHIR) (typical expansion
medium for naive PSCs) with or without Dox (Figure 1D).
Surface marker expression by naive PSCs was analyzed by
flow cytometry. Under naive-PSC culture conditions,
around 40% of E-cadherin upregulated mouse EpiSCsfficient Conversion to Naive-like PSCs in the Presence of LIF
ssion of E-cadherin transgene.
SC), mouse EB3DR epiblast stem cells (EpiSC), and transgenic mouse
ays (Dox, Dox+). b-ACTIN was used as a loading control.
use EB3DR EpiSCs cultured with (blue line) or without (red line)
use EB3DR EpiSCs. Culture conditions were defined as primed (ESM +
d) under various conditions. Shown are the percentages of CD31-
s under primed (ESM + bFGF) and naive (N2B27 + LIF) conditions.
equency of PECAM1-expressing cells is significantly increased in
SEM of three independent experiments, *p < 0.05).
LIF, shifts of E-cadherin upregulated mouse EpiSCs to PECAM1-ex-
ions (mean ± SEM of three independent experiments, *p < 0.05, and
dherin upregulated mouse EpiSCs in the presence of LIF. Almost all
le bar, 50 um.
-rESCs.
outi) into BDF1 3 C57BL/6 blastocysts (black) show coat-color
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Reprogramming of Epiblast Stem Cellsconverted to expression of the naive-PSC marker CD31
(PECAM1) in 7 days (Figure 1E). In the presence of LIF,
the frequencies of PECAM1-expressing cells were signifi-
cantly increased among E-cadherin upregulated mouse
EpiSCs compared to those cultured under other conditions
for 7 days (Figures 1F and 1G). These data suggest that over-
expression of E-cadherin considerably increases the effi-
ciency with which primed mouse EpiSCs convert to naive
PSCs upon activation of the LIF signal. PECAM1-expressing
cells obtained from E-cadherin upregulated EpiSCs formed
dome-like compact colonies (Figure 1H). We call these cells
mouse EpiSCs reprogrammed to ESC-like status by E-cad-
herin overexpression (mouse E-cad-rESCs).
Wenext examined the developmental potential ofmouse
E-cad-rESCs. After injection into mouse blastocysts, mouse
E-cad-rESCs from mouse EB3DR-EpiSCs (DsRed-marked
EpiSCs) contributed to chimeric live-born mice (Figure 1I).
We also succeeded in generation of chimeric mice by in-
jection of mouse E-cad-rESCs (normally giving rise to
agouti-furred mice) into BDF1 3 C57BL/6 mouse blasto-
cysts (normally giving rise to black-furred mice). The chi-
meras showed coat-color contributions from the mouse
E-cad-rESCs (Figure 1J; Table S2), indicating that mouse
E-cad-rESCs contributed extensively to development.
We also tested effect of E-cadherin overexpression in a
‘‘standard’’ mouse EpiSC line (Tesar et al., 2007) to confirm
reproducibility (Figure S1). The ‘‘standard’’ mouse EpiSCs
were labeled with tdTomato to distinguish with mouse em-
bryonic fibroblasts (MEFs). The cells were infectedwith len-
tiviral vector, which expresses tdTomato under CAG pro-
moter. Flow-cytometry analyses showed that ‘‘standard’’
mouse EpiSCs overexpressing E-cadherin converted to
CD31-expressing naive-like cells within 7 days (FiguresFigure 2. Wnt Signaling Inhibitor Facilitates Generation of Naive
(A) Western blots of b-CATENIN and active b-CATENIN in wild-type
cultured with or without doxycycline (2 mg/ml) for 2 days (Dox, Do
HISTON H3 were used as loading controls in cytoplasmic and nuclear fr
(upper-right panel) and proportion of b-CATENIN in cytoplasmic and
(B) Western blotting analyses for phospho-STAT3 in mouse EB3DR E
EB3DR EpiSCs cultured with or without doxycycline (2 mg/ml) for 2 d
(C) Western blots of b-CATENIN and active b-CATENIN in mouse EpiS
Cytoplasmic and nuclear fractions were analyzed. b-ACTIN and HIST
fractions, respectively.
(D) Timeline of naive-like cell induction using 5 nM IWP-2 and 1 m
Treatment was maintained for 7 and 14 days.
(E) Morphological observation of colonies derived from treated mous
colonies (black arrowheads). Efficiency of generation of naive-like com
naive-like compact colonies was calculated as the ratio of seeded cell n
four independent experiments, *p < 0.05). Scale bar, 100 mm.
(F) FACS analysis of PECAM1 expression levels in mouse EpiSCs cultur
(G) Average of PECAM1-expressing cells associated with (F). The frequ
treatment (mean ± SEM of three independent experiments, **p < 0.0
See also Figure S2.
Stem CeS1B and S1C), as did EB3DR-EpiSCs. Because ‘‘standard’’
EpiSCs were a female line, we sorted CD31-expressing cells
and established an E-cad-rESC line and then analyzed X
chromosome inactivation (XCI) state immunocytoche-
mically (Figure S1D). Although XCI was observed in
nontreated EpiSCs (marked by dot-like expression of
H3K27me3), no XCI was observed in converted cells.
These results suggest that upregulation of E-cadherin in
the presence of LIF enables highly efficient derivation of
naive-like PSCs.
Ohtsuka et al. (2012) reported that 2 days of E-cadherin
overexpression enabled chimera formation with mainte-
nance of primed-state pluripotency; however, the EpiSC
lines that we used did not contribute to chimeras when
cultured ‘‘ESM plus bFGF’’ medium or ‘‘N2B27 plus LIF’’
medium (Table S2). In our hands, reprogramming was
necessary for EpiSCs into which the E-cadherin tet-on sys-
tem had been introduced to form chimeras with preim-
plantation embryos.
Inhibition of Nuclear Translocation of b-CATENIN
Enhances Reprogramming Efficiency
E-CADHERIN specifically binds to b-CATENIN and regu-
lates its nuclear translocation (Conacci-Sorrell et al.,
2003; Sasaki et al., 2000; Stockinger et al., 2001). Accumu-
lation of nonphosphorylated b-CATENIN in the nucleus is
required for b-CATENIN-mediated transcription (Staal
et al., 2002). Thus, we hypothesized that E-CADHERIN
overexpression trapped b-CATENIN in cytoplasm, thereby
preventing intranuclear b-catenin signaling. To examine
this, we quantitated b-CATENIN and nonphosphorylated
b-CATENIN (active form) in cytoplasmic and nuclear
fractions by western blotting (Figure 2A). Images andPluripotency Marker-Positive Cells from Mouse EpiSCs
mouse EpiSC and mouse EpiSC with inducible E-cadherin transgene
x+). Cytoplasmic and nuclear fractions were analyzed. b-ACTIN and
actions, respectively (left panel). Relative expression of b-CATENIN
nuclear fractions (right-lower panel) in each condition are shown.
SCs (ESC), mouse EB3DR EpiSC (wild-type), and transgenic mouse
ays (Dox, Dox+). b-ACTIN was used as a loading control.
Cs cultured with or without 5 nM IWP-2 for 2 days (DMSO, IWP-2).
ONE H3 were used as loading controls in cytoplasmic and nuclear
M PD0325901 in the presence of LIF. DMSO was used as control.
e EpiSCs (upper panel). Note the appearance of naive-like compact
pact colonies at 14 days (lower panel). Efficiency of generation of
umber to the number of naive-like compact colonies (mean ± SEM of
ed with (blue line) or without (red line) IWP-2 for 7 and 14 days.
ency of PECAM1-expressing cells increased significantly with IWP-2
1, and ***p < 0.001).
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Figure 3. Developmental Potential of
Mouse wit-rESCs
(A) Photomicrograph of PECAM1-expressing
cells obtained from IWP-2-treated mouse
EpiSCs in the presence of LIF (wit-rESCs).
Almost all PECAM1-expressing cells occurred
as dome-like compact colonies. Scale bar,
100 mm.
(B) DsRed-marked mouse wit-rESCs
contribute to chimeric embryos at E12.5. An
embryo lacking DsRed expression is shown
as a nonchimera.
(C) Live-born chimeric mice were obtained
from DsRed-marked mouse wit-rESCs. A pup
lacking DsRed expression is shown as a
nonchimera.
(D) Chimeric mice obtained from injection of mouse wit-rESCs (agouti) into BDF1 3 C57BL/6 blastocysts (black) show coat-color
contribution from mouse wit-rESCs.
(E) Germline-transmitted agouti coat color is shown in pups born to mice obtained from wit-rESCs.
See also Figure S3 and Table S2.
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ENIN in the nuclear fraction is decreased in Dox-treated
EpiSCs into which the E-cadherin tet-on system had been
introduced. (Such cells manifested an intermediate phe-
notype even without Dox treatment, reflecting leaky re-
gulation of the tet-on system.) These results showed that
overexpression of E-cadherin inhibits nuclear translocation
of b-CATENIN in mouse EpiSCs.
E-CADHERIN reportedly also is responsible for LIF signal
integration (del Valle et al., 2013). We therefore tested the
effect of E-cadherin overexpression on LIF-STAT3 signaling
in EpiSCs. We quantitated phospho-STAT3 (p-STAT3) by
western blotting analysis with or without E-cadherin over-
expression (Figure 2B). In the presence of LIF, EpiSCs over-
expressing E-cadherin showed higher expression of p-STAT3
than control cells. This suggests that E-cadherin overexpres-
sion not only blocks nuclear translocation of b-CATENIN,
but also enhances LIF-STAT3 signaling when EpiSCs are
cultured with LIF.
We wondered whether attenuation of b-catenin signaling
or enhancement of LIF-STAT3 signaling was mainly respon-
sible for the promotion of reprogramming. To answer this
question, we used the small-molecule inhibitor IWP-2,
which interferes with the ability of cells to produce WNT
proteinsbyblockingPorcupine, an enzymeessential for acyl-
atingWNT proteins, and results in suppression of accumula-
tion of b-CATENIN (Chen et al., 2009). As was the case for
E-cadherin overexpression, we found that IWP-2 inhibits
nuclear translocation of b-CATENIN in mouse EpiSCs (Fig-
ure 2C). We then investigated whether IWP-2 can induce
efficient reprogramming. For thispurpose,wechosea combi-
nationofLIF andPD(NicholsandYing,2006),withDMSOas
acontrol, andcompared itwithacombinationofLIF, PD,and
IWP-2 (Figure2D).Morphological examination founddome-108 Stem Cell Reports j Vol. 4 j 103–113 j January 13, 2015 j ª2015 The Autlike compact colonies derived from mouse EpiSCs treated
with IWP-2. After 14 days in culture, the frequency of
naive-like colonies was significantly increased in the IWP-
2-treated mouse EpiSCs compared with the DMSO-treated
control and with CHIR-treated mouse EpiSCs (Figure 2E).
Flow-cytometry analyses revealed that IWP-2-treated mouse
EpiSCs convert to cells that express the naive-ESC marker
CD31 (PECAM1-expressing cells) within 7 days (Figures 2F
and2G).PECAM1-expressingcellsobtained fromWnt inhib-
itor-treated mouse EpiSCs formed mouse ESC-like colonies
(Figure 3A). We called these cells Wnt inhibitor-treated
mouse EpiSCs reprogrammed to ESC-like cells (mouse wit-
rESCs). Next, we examined the developmental potential of
mouse wit-rESCs. When injected into mouse blastocysts,
mouse wit-rESCs from EB3DR-EpiSCs, which are DsRed-
marked, contributed to chimeric embryos at E12.5 (Fig-
ure 3B). Furthermore, live-born and adult chimeric mice
were obtained from mouse wit-rESCs (Figures 3C and 3D),
indicating that mouse wit-rESCs contributed extensively to
development. Those wit-rESC-derived chimeras also showed
germline transmission (Figure 3E).
To assess reprogramming quantitatively, we next used
Rex1GFPd2 cells, in which GFP is expressed via the Rex1
(Zfp42) locus (Wray et al., 2011). Rex1 is specifically ex-
pressed in naive-state pluripotent cells and is downregu-
lated at the onset of differentiation (Toyooka et al., 2008;
Wray et al., 2010). We injected Rex1-GFP mouse ESCs
into tetraploid (4N) embryos and obtained a GFP-negative
Rex1-GFP mouse EpiSC line from postimplantation em-
bryos (E6.5) (Figures S2A–S2C). In the reprogramming
process, the frequency of cells expressing both GFP and
PECAM1 (‘‘double-positive’’ cells) was significantly
increased among IWP-2-treated mouse EpiSCs compared
to the DMSO-treated control (Figures S2D and S2E).hors
Figure 4. Gene Expression Profiling of
Various Mouse Stem Cell Lines
(A) RT-PCR of pluripotency genes. Note
naive marker gene expression by mouse
E-cad rESC and wit-rESC lines.
(B) Real-time PCR of primed pluripotency
genes in mouse E-cad-rESCs, wit-rESCs, and
EpiSCs. Expression levels of pluripotency
genes are compared to those in mouse ESCs.
Expression values are normalized to Gapdh.
Data are represented as mean ± SEM of three
independent experiments.
(C) Real-time PCR analysis for naive plurip-
otency genes in mouse E-cad-rESCs, wit-
rESCs, and EpiSCs. Expression levels of
pluripotency genes are compared to those in
mouse ESCs. Relative expression values are
normalized to Gapdh.
Data represent mean ± SEM of three inde-
pendent experiments, *p < 0.05, **p < 0.01,
and ***p < 0.001. Note that expression
patterns in mouse E-cad-rESCs and wit-rESCs
resemble those in mouse ESCs, but not those
in mouse EpiSCs.
See also Figure S4 and Table S1.
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small-molecule inhibitor that promotes degradation of
b-CATENIN (Huang et al., 2009), to confirm that enhance-
ment of reprogramming efficiency was reproducible. Upon
XAV939 treatment in the presence of LIF, the configuration
ofmouse EB3DR EpiSCs indeed changed to that of ESC-like
compact colonies expressing PECAM1 (Figures S3A and
S3B). Moreover, PECAM1-expressing cells reprogrammed
byXAV939 treatment contributed to chimeras (Figure S3C).
These results clearly indicate that blocking nuclear localiza-
tion of b-CATENIN significantly enhances conversion effi-
ciency of mouse EpiSCs to naive-like PSCs.
Mouse E-Cad-rESCs and wit-rESCs Express Naive
Pluripotency Genes
To gain insight into the processes bywhich reprogramming
occurs inmouse EpiSCs, we examined gene-expression pro-
files by RT-PCR analysis. We found that the naive pluripo-Stem Cetency genes Stella and Rex1 are expressed in all lines of
mouse E-cad-rESC and wit-rESC that we established (Fig-
ure 4A). Furthermore, real-time PCR analysis revealed that
mouse E-cad-rESCs and wit-rESCs showed high expression
of the naive pluripotency genes Pecam1, Rex1, and Kit (also
called c-kit) (Figure 4C). However, expression of the primed
pluripotency genes Lefty1 and Fgf5 was scant (Figure 4B).
Expression of the major pluripotency genes Nanog and
Sox2 was also increased in mouse E-cad-rESCs and wit-
rESCs compared to expression inmouse EpiSCs (Figure 4C).
These results indicate that the gene expression profiles of
mouse E-cad-rESCs and wit-rESCs are similar to those of
mouse ESCs and differ from those of mouse EpiSCs.
TCF/LEF Activity in E-cadherin-Overexpressing or
Inhibitor-Treated EpiSCs
To investigate whether blocking nuclear localization of
b-CATENIN result in downregulation of TCF transcriptionalll Reports j Vol. 4 j 103–113 j January 13, 2015 j ª2015 The Authors 109
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Reprogramming of Epiblast Stem Cellsactivity, we measured TCF/LEF activity by TOPFlash assay
(Veeman et al., 2003). Upon overexpression of E-cadherin,
luciferase activity did not differ significantly between the
tet-on E-cadherin construct-carrying EpiSCs and their
parental EB3DR EpiSCs, regardless of Dox treatment (Fig-
ure S4A). Furthermore, we examined the effect of luciferase
activity on EB3DREpiSCs treatedwithWnt signaling inhib-
itors (Figure S4B). Luciferase activity did not differ signifi-
cantly in IWP-2- or XAV939-treated cells from that in
DMSO-treated controls. Although E-cadherin overexpres-
sion or IWP-2 treatment blocked b-CATENIN localization
in nuclei (Figures 2A and 2C), downregulation of TCF/LEF
activity was not detected. These results may suggest that
improvement of reprogramming efficiency (Figures 1E,
2E, and 2G) was achieved via an unknown signaling
pathway that was stimulated by blocking b-CATENIN
translocation.DISCUSSION
Conversion of mouse EpiSCs to ESC-like cells in response
to LIF-STAT3 signaling rarely occurs under ordinary cell
culture conditions (Bao et al., 2009). Indeed, a recent
study has shown that upregulation of E-cadherin expres-
sion does not induce conversion from primed to naive
state under culture in media containing bFGF and activin
A (Ohtsuka et al., 2012). However, we demonstrated that
overexpression of E-cadherin in combination with the
cytokine LIF yields highly efficient derivation of cells
that express naive-PSC markers and that can contribute
to chimeras. We then extended these data by confirming
E-cadherin-dependent induction of naive PSC markers
and repression of primed PSC markers in the presence of
LIF. These results suggest that overexpression of E-cadherin
induces conversion of mouse EpiSCs toward the ESC-like
naive state.
Ohtsuka et al. (2012) showed that 2 days of E-cadherin
overexpression enabled chimera formation by EpiSCs
without any evident conversion to ESC-like cell status.
However, the EpiSC lines that we used did not acquire
the ability to form chimeras after short-term (2 days) over-
expression of E-cadherin. To explain this discrepancy, two
possibilities can be considered. One is differences in culture
conditions. Ohtsuka et al. maintained EpiSCs with activin
and FGF2 under feeder-free conditions, whereas we main-
tained EpiSCs in a different medium supplemented with
bFGF and on feeder cells. Different culture conditions
might set EpiSCs at slightly different stages within the
primed pluripotent state and might result in different out-
comes with respect to chimera formation after E-cadherin
overexpression. The other is use of different vector systems
to induce E-cadherin overexpression.We used the all-in-one110 Stem Cell Reports j Vol. 4 j 103–113 j January 13, 2015 j ª2015 The Auttet-on lentiviral vector system (Yamaguchi et al., 2012),
whereas Ohtsuka et al. used the piggyBack transposon sys-
tem. Of importance may be that they described E-cadherin
expression levels in EpiSC-line cells into which the tet-on
system had introduced E-cadherin as ‘‘slightly higher’’
than those in ESCs, whereas cells in our line showed
much higher expression than did ESCs after Dox treatment
in a ‘‘standard’’ mouse EpiSC line. This may suggest that E-
cadherin expression levels must be similar to those in ESCs
to permit integration into the ICM.
As with reprogramming factors (Oct4, Klf2, Sox2, and
c-Myc), overexpression of E-cadherin enhances the effi-
ciency of iPSC generation from mouse embryonic fibro-
blasts (Chen et al., 2010). We demonstrated that E-cadherin
overexpression affects both attenuation of b-catenin
signaling and enhancement of LIF-Stat3 signaling. These
changes might underlie efficient reprogramming. We
consider blocking nuclear localization of b-CATENIN to
be a major factor because Wnt inhibitors also promoted
reprogramming.
We also demonstrated that although innate E-cadherin
expression levels vary among EpiSC lines, E-cadherin overex-
pression supported reprogramming independent of innate
expression levels. This may suggest that, rather than abso-
lute b-catenin signal intensity, the relative change in b-cate-
nin signaling is important.
Consistent with reports indicating such a role for
E-CADHERIN (Conacci-Sorrell et al., 2003; Sasaki et al.,
2000; Stockinger et al., 2001), our data confirmed negative
regulation of nuclear translocation of b-CATENIN through
E-cadherin overexpression in mouse EpiSCs. As expected,
we could also demonstrate that blocking nuclear localiza-
tion of b-CATENIN by the small-molecule inhibitors
IWP-2 or XAV939 confers high efficiency in conversion
of mouse EpiSCs to naive-like PSCs that can contribute
to chimeras. This suggests that, as was the case with upre-
gulation of E-cadherin expression, the combination of
blocking nuclear localization of b-CATENIN and LIF
signaling activation primes mouse EpiSCs for reprogram-
ming. Absent upregulation of E-cadherin, small-molecule
inhibitors of Wnt signaling can significantly amplify re-
programming frequency. One can infer that upregulation
of E-cadherin leads efficient reprogramming by blocking
nuclear localization of b-CATENIN. In this way, we suc-
ceeded in establishing culture conditions for efficient con-
version of primed PSCs to naive-like PSCs. To our surprise,
we demonstrated that E-cadherin overexpression and Wnt
inhibitor treatments did not affect to TCF/LEF-mediated
transcriptional activity though nuclear localization of
b-CATENIN was significantly blocked. Kim et al. (2013)
previously reported that subcellular localization of b-CAT-
ENIN does not implicate Wnt-downstream transcriptional
activity but has some role in maintenance of self-renewal.hors
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signaling is stimulated by blocking nuclear localization or
subcellular localization of b-CATENIN, thereby also pro-
moting conversion from primed state to naive state
pluripotency.
Pluripotentiality in primate PSCs resembles pluripoten-
tiality in mouse EpiSCs; primate PSCs are not thought to
contribute to chimeras (Nichols and Smith, 2009). For
this reason, the use of primate PSCs for knockout and trans-
genic studies is rare. Although our work was done only in
mice, our findings, with efficient conversion of primed to
naive PSCs, may provide the key to establishing naive
PSCs derived from other animals. We consider that require-
ments for b-catenin signaling must be reassessed, because
the culture conditions employed in reports of establish-
ment of human naive PSCs all were set to promote b-cate-
nin signaling (Gafni et al., 2013; Hanna et al., 2010; Li
et al., 2009; Ware et al., 2014). Further study would be
required to clarify the effect of b-catenin signaling for the
conversion to naive-like state in other animals and human
PSCs.
Our studies indicate that blocking nuclear localization of
b-CATENIN can enhance conversion of primed mouse
PSCs to naive-like PSCs. Further studies of this phenome-
non may not only provide better understanding of gene
regulatory circuits underlying pluripotency, but perhaps
also provide processes to induce reprogramming in primed
PSCs.EXPERIMENTAL PROCEDURES
Lentiviral Vector Construction and Preparation
An E-cadherin inducible lentiviral vector was derived from the self-
inactivating lentiviral vector CS-TRE-PRE-Ubc-tTA-I2G (Yamagu-
chi et al., 2012). Mouse E-cadherin was amplified by PCR using
the primers 50-CGTACGCCACCATGGGAGCCCGGTGCCGCAG-
30 and 50-GAATTCCTAGTCGTCCTCACCACCGC-30 (restriction
sites are underlined). Amplified E-cadherin was cloned into the
PCR-Blunt II-TOPO cloning vector (Invitrogen), and its incorpora-
tion was confirmed by sequencing. A BsiWI-EcoRI fragment of
TOPO E-cadherin was then inserted into BsiWI-EcoRI sites of CS-
TRE-PRE-Ubc-tTA-I2G, resulting in CS-TRE-mouse E-cadherin-
PRE-Ubc-tTA-I2G.Derivation of DsRed-Marked EpiSC Lines and Culture
Conditions of PSCs
This study used the three mouse EpiSC lines EB3DR EpiSC, Rex1-
GFP EpiSC, and the EpiSC reported by Tesar et al. (2007) and the
two mouse ESC lines EB3DR ESC (Niwa et al., 2002; Ogawa et al.,
2004) and Rex1-GFP ESC (Toyooka et al., 2008; Wray et al., 2010,
2011). To generate DsRed-marked mouse EpiSCs, we injected
EB3DR ESCs into blastocyst embryos and established an EpiSC
line from E6.5 embryos as described (Tesar et al., 2007). The endo-
dermal layers of E6.5 embryos collected from the uterus wereStem Cepeeled off manually with glass needles and were transferred onto
mitomycin-C-treated mouse embryonic fibroblasts (MEFs) in
primed PSCs medium consisting of DMEM-F12, 20% knockout
serum replacement, 1 mM sodium pyruvate, 1 3 nonessential
amino acids, 0.66 mM 2-mercaptoethanol (all Gibco), and
5 ng/ml human basic FGF (bFGF, PeproTech) (‘‘ESM plus bFGF’’).
Growing colonies were observed within a few days. Colonies
expressing DsRed were picked up and passaged with 10 mM Y-
27632. After several passages, mouse EpiSCs usually were stably
self-renewing. All mouse ESC lines were cultured on gelatin-coated
plates in N2B27medium (Ying et al., 2008) containing 1,000 U/ml
of mouse leukemia inhibitory factor (LIF; Millipore) (‘‘N2B27 plus
LIF’’). The effects of 1 mM PD0325901 (Axon), of 3 mMCHIR99021
(Axon), of 5 nM IWP-2 (Wako), and of 10 mM XAV939 (Sigma-Al-
drich) on the conversion of mouse EpiSCs to naive-like status
were examined.
Flow-Cytometry Analysis
For FACS analysis, single-cell suspensions were stained with APC-
conjugated anti-mouse CD31 antibody (BD Biosciences) and
anti-CD324 (E-CADHERIN) antibody (BD Biosciences). The
stained cells were analyzed and sorted by FACSCalibur (BD Biosci-
ences) and FACSAria II (BD Biosciences), respectively.
Western Blot Analysis
Whole-cell lysates were prepared using lysis buffer (complete Lysis-
M, EDTA-free; Roche), and nuclear and cytoplasmic fractions were
prepared by using a Nuclear/Cytosol Fractionation Kit (BioVision
Technologies) in accordance with the manufacturer’s instructions.
After centrifugation, the supernatants were dissolved in Laemmli
Sample Buffer (Bio-Rad) for SDS-PAGE. Cell lysates were separated
by SDS-PAGE, electroblotted onto polyvinylidene fluoride (PVDF)
transfer membranes (Millipore), and probed with primary anti-
bodies. After incubation with horseradish-peroxidase-conjugated
secondary antibody (GE Healthcare UK), labeled proteins were de-
tected using SuperSignal West Pico Chemiluminescent Substrate
(Thermo Scientific). Primary antibodies against b-CATENIN
(1:1000), nonphospho (active) b-CATENIN (1:1,000), E-CADHERIN
(1:1,000), STAT3 (1:2,000), p-STAT3 (1:2,000), b-ACTIN (1:1,000),
andHISTONEH3 (1:2,000) were employed (all Cell Signaling Tech-
nology). For quantification of protein expression levels, blotted im-
ages were captured by LAS 4000 equipment (GE Healthcare) and
determined by ImageQuant TL software (GE Healthcare). Relative
value was calculated the ratio of signal intensity of loading control
to signal intensity of b-CATENIN in cytoplasmic and nuclear frac-
tions, respectively.
Embryo Manipulation for Chimera Formation Assay
Chimera formation was assayed as described (Kobayashi et al.,
2010). Mouse 8-cell/morula-stage embryos collected in M2 me-
dium (Millipore) from the oviduct and the uterus of BDF1 3
C57BL/6 mice 2.5 days postcoitum (dpc) were transferred into
KSOM-AA medium (Millipore) and were cultured for 24 hr before
blastocyst injection. For micromanipulation, trypsinized PSCs
were suspended in PSC culture medium. A piezo-driven microma-
nipulator (Prime Tech) was used to drill zona pellucida and tro-
phectoderm under the microscope, and ten PSCs were introducedll Reports j Vol. 4 j 103–113 j January 13, 2015 j ª2015 The Authors 111
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jection, embryos underwent follow-up culture for 1–2 hr, after
which they were transferred into the uteri of pseudopregnant
recipient ICR mice (2.5 dpc).RT-PCR and Quantitative Real-Time PCR Analysis
Total RNA was isolated using an RNAeasy kit (QIAGEN) followed
by cDNA synthesis using SuperScript III reverse transcriptase (Invi-
trogenCA). PCR was performed using rTaq (Takara Bio) with con-
ditions of 94C for 1 min, followed by 30 cycles of 94C for 30 s,
annealing temperature (55C) for 30 s, and 72C for 1 min, with
a final extension at 72C for 7min. The primer sequences are listed
in Table S1. Pluripotency gene profiles were assayed by quantita-
tive real-time PCR using TaqMan Mouse Stem Cell Pluripotency
Array v2.0 (Applied Biosystems) according to the manufacturer’s
instructions.Statistical Analysis
The results are presented as the mean ± SEM. Student’s two-tailed
nonpaired t test was used to determine the statistical significance
of differences. Significant differences were defined as *p < 0.05,
**p < 0.01, and ***p < 0.001.
All experiments were performed under institutional guidelines.
Animal experiments were performed with approval of the Insti-
tutional Animal Care and Use Committee of the Institute of Med-
ical Science, University of Tokyo.
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